rSIFN-co Uses, Dosage, Side Effects and more
Recombinant super-compound interferon (rSIFN-co) is a recombinant version of interferon alpha with modified spatial configuration. This interferon has antiviral and antitumor activity.
| Attribute | Details |
|---|---|
| Trade Name | rSIFN-co |
| Generic | Recombinant Super-Compound Interferon |
| Recombinant Super-Compound Interferon Other Names | rSIFN-co |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How rSIFN-co works
RSIFN-co has immunomodulation, antiviral, and antineoplastic activities. It binds to IFN-specific cell surface receptors and causes transcription and translation of genes that have protein products with antiviral, antiproliferative, anticancer, and immunomodulating effects. It is currently being investigated for viral diseases and cancer.
